Sleep apnea devices market will reach US$ 9.95 Billion by 2030. Sleep apnea, a prevalent sleep disorder, and results in frequent interruptions in breathing during sleep. Individuals affected by sleep apnea often exhibit symptoms like loud snoring and daytime drowsiness. This disorder involves recurring episodes of reduced or halted breathing for short durations while asleep. Despite these interruptions leading to periodic awakenings and a decline in sleep quality, individuals may not fully awaken, remaining unaware of the abnormality in their nighttime breathing.
Sleep apnea, a sleep problem with often two type, is characterized by the primary and more prevalent type, known as Obstructive Sleep Apnea (OSA). In OSA, the muscles within the throat relax during sleep, obstructing the airflow to the lungs. The 2nd type is Central Sleep Apnea (CSA), in which the brain fails to signal the respiration muscle mass. Additionally, there exists a 3rd variation called treatment-emergent primary or complex sleep apnea, which happens when an individual to begin with recognized with OSA all through a sleep study at subsequently develops CSA because of OSA treatment.
Several key elements are propelling the market, along with the growing incidence of sleep apnea, a rise within the growing old populace, an upsurge in the superiority of weight problems and hypertension, and a growing awareness amongst patients in growing nations. The aging old demographic emerges as a substantial driver of market increase for sleep apnea devices, with the elderly being particularly susceptible to this disorder. According to the World Population Prospects 2022, the percentage of humans over 65 is projected to growth from 10% in 2022 to 16% in 2050. By 2050, the range of people over 65 is anticipated to be twice that of children beneath 5 years antique and approximately identical to that of children beneath 12.
The anticipated enlargement of the global sleep apnea market is bolstered by the capability advantages of mHealth and telemedicine in enhancing the control and prognosis of sleep apnea. Numerous studies emphasize that a crucial factor for long-time period CPAP (Continuous Positive Airway Pressure) compliance is patient adherence all through the initial weeks of medication. To enhance compliance, prompt follow up and support at during this period are essential. Telemedicine serves as a valuable for supplying such support, especially when extended waiting lists pose challenges in delivering timed assistance. Several research advocate that patients in the telemedicine organization explicit high satisfaction with their care, mainly appreciating convenience of live video consultations with doctors and consultants. As of 2023, the worldwide sleep apnea devices market is worth US$ 6.06 Billion.
Pulse oximeters are widely employed for measuring blood hemoglobin oxygen saturation, offering a continuous and relatively non-invasive assessment. Their convenience has made them a ubiquitous tool in hospitals and healthcare settings. The application of pulse oximetry extends to investigating and diagnosing obstructive sleep apnea in adults and children, involving various practices. When incorporated into overnight polysomnograms (PSG), pulse oximeters enable the interpretation of data patterns in conjunction with events in other physiological channels, potentially providing a detailed characterization of pathophysiology. Furthermore, the growing global prevalence of sleep apnea is anticipated to propel this segment's growth throughout the forecast period.
The report titled "Sleep Apnea Devices Market, Global Forecast, by Types [Therapeutics (CPAP Sleep Apnea Therapeutic Devices, Auto CPAP Sleep Apnea Therapeutic Devices, BiPAP Sleep Apnea Therapeutic Devices and Adaptive Servo-Ventilation (ASV)) and Diagnostics (Polysomnography Devices (PSG), Oximeter, Actigraphy Monitoring Device, Respiratory Polygraph and Sleep Apnea Screening Device)], End Users (Sleep Laboratories, Clinics & Hospitals and Home Care Settings/Individuals), Region (North America (United States, Mexico, Canada), Europe (Germany, United Kingdom, France, Italy, Spain, Switzerland), Asia Pacific (Japan, China, India, Australia, South Korea, Indonesia), South America (Brazil, Argentina), Middle East & Africa (South Africa, Saudi Arabia, United Arab Emirates) and Rest of world), Company (Carefusion Corp, Somnomed, ResMed Inc., Koninklijke Philips N.V., Compumedics Limited (CMP), Nihon Kohden Corporation, Natus Medical Incorporated and Teleflex Incorporated)" provides a detailed analysis of Worldwide Sleep Apnea Devices Industry.
2. Diagnostic Devices
2. Auto CPAP Sleep Apnea Therapeutic Devices
3. BiPAP Sleep Apnea Therapeutic Devices
4. Adaptive Servo-Ventilation (ASV)
2. Oximeter
3. Actigraphy Monitoring Device
4. Respiratory Polygraph
5. Sleep Apnea Screening Device
2. Home Care Settings/Individuals
1.1 United States
1.2 Canada
2. Europe
2.1 Germany
2.2 United Kingdom
2.3 France
2.4 Italy
2.5 Spain
2.6 Switzerland
3. Asia - Pacific
3.1 Japan
3.2 China
3.3 India
3.4 South Korea
3.5 Indonesia
3.6 Australia
4. Latin America
4.1 Mexico
4.2 Brazil
4.3 Argentina
5. Middle East & Africa
5.1 South Africa
5.2 Saudi Arabia
5.3 United Arab Emirates
6. Rest of World
2. Somnomed
3. ResMed Inc.
4. Koninklijke Philips N.V.
5. Compumedics Limited (CMP)
6. Nihon Kohden Corporation
7. Natus Medical Incorporated
8. Teleflex Incorporated
Sleep apnea, a sleep problem with often two type, is characterized by the primary and more prevalent type, known as Obstructive Sleep Apnea (OSA). In OSA, the muscles within the throat relax during sleep, obstructing the airflow to the lungs. The 2nd type is Central Sleep Apnea (CSA), in which the brain fails to signal the respiration muscle mass. Additionally, there exists a 3rd variation called treatment-emergent primary or complex sleep apnea, which happens when an individual to begin with recognized with OSA all through a sleep study at subsequently develops CSA because of OSA treatment.
Sleep Apnea market is predicted to grow at a CAGR of 7.34% from 2024 to 2030
Sleep disorders present considerable clinical challenges, affecting one in three individuals at some point in their lives. Sleep apnea, an extreme and probably life-threatening sleep situation, frequently goes remains and untreated. However, numerous governmental efforts are tackling the worries of those with Obstructive Sleep Apnea (OSA). The American Sleep Apnea Association (ASAA) within the United States, a non-profit organization dedicated to raising attention of sleep apnea, works in the direction of continual upgrades in medicines and advocates for the welfare of people grappling with sleep apnea.Several key elements are propelling the market, along with the growing incidence of sleep apnea, a rise within the growing old populace, an upsurge in the superiority of weight problems and hypertension, and a growing awareness amongst patients in growing nations. The aging old demographic emerges as a substantial driver of market increase for sleep apnea devices, with the elderly being particularly susceptible to this disorder. According to the World Population Prospects 2022, the percentage of humans over 65 is projected to growth from 10% in 2022 to 16% in 2050. By 2050, the range of people over 65 is anticipated to be twice that of children beneath 5 years antique and approximately identical to that of children beneath 12.
The anticipated enlargement of the global sleep apnea market is bolstered by the capability advantages of mHealth and telemedicine in enhancing the control and prognosis of sleep apnea. Numerous studies emphasize that a crucial factor for long-time period CPAP (Continuous Positive Airway Pressure) compliance is patient adherence all through the initial weeks of medication. To enhance compliance, prompt follow up and support at during this period are essential. Telemedicine serves as a valuable for supplying such support, especially when extended waiting lists pose challenges in delivering timed assistance. Several research advocate that patients in the telemedicine organization explicit high satisfaction with their care, mainly appreciating convenience of live video consultations with doctors and consultants. As of 2023, the worldwide sleep apnea devices market is worth US$ 6.06 Billion.
CPAP Sleep Apnea Therapeutic Devices captured largest market share and Pulse Oximeters Diagnostics device will hold the most important market in the Sleep Apnea Industry
By Products Types, global sleep apnea market is segmented into Therapeutics(CPAP Sleep Apnea Therapeutic Devices, Auto CPAP Sleep Apnea Therapeutic Devices, BiPAP Sleep Apnea Therapeutic Devices and Adaptive Servo-Ventilation (ASV)) and Diagnostics(Polysomnography Devices (PSG), Oximeter, Actigraphy Monitoring Device, Respiratory Polygraph and Sleep Apnea Screening Device).Therapeutic Devices have gained a significant share in the market for sleep apnea devices. These devices play a crucial role in managing sleep apnea by providing a consistent and continuous flow of air that keeps the airways open. The effectiveness of CPAP devices in alleviating symptoms and improving sleep quality has contributed to their dominance in the market. CPAP devices are considered a cornerstone of sleep apnea treatment and are at the forefront of addressing the rising global demand for effective therapeutic solutions in sleep medicine.Pulse oximeters are widely employed for measuring blood hemoglobin oxygen saturation, offering a continuous and relatively non-invasive assessment. Their convenience has made them a ubiquitous tool in hospitals and healthcare settings. The application of pulse oximetry extends to investigating and diagnosing obstructive sleep apnea in adults and children, involving various practices. When incorporated into overnight polysomnograms (PSG), pulse oximeters enable the interpretation of data patterns in conjunction with events in other physiological channels, potentially providing a detailed characterization of pathophysiology. Furthermore, the growing global prevalence of sleep apnea is anticipated to propel this segment's growth throughout the forecast period.
Sleep Laboratories, Clinics & Hospitals will have a maximum market share
By End User, global sleep apnea market is divided into Sleep Laboratories, Clinics & Hospitals and Home Care Settings/Individuals. The market for Sleep Laboratories, Clinics & Hospitals is witnessing significant growth as the demand for comprehensive sleep disorder diagnosis and treatment rises. Sleep labs, clinics, and hospitals play a crucial role in addressing conditions like sleep apnea, insomnia, and other sleep-related disorders. These facilities conduct diagnostic tests such as polysomnography to monitor various physiological parameters during sleep. Increasing awareness of the impact of sleep on overall health has led to a surge in patients seeking professional evaluation. The market's growth is further fueled by advancements in sleep medicine, technology, and the adoption of telemedicine for remote patient monitoring, enhancing accessibility to sleep-related healthcare services.China Sleep Apnea industry thriving worldwide
By Countries, global sleep apnea market is divided into North America (United States, Mexico, Canada), Europe (Germany, United Kingdom, France, Italy, Spain, Switzerland), Asia Pacific (Japan, China, India, Australia, South Korea, Indonesia), South America (Brazil, Argentina), Middle East & Africa (South Africa, Saudi Arabia, United Arab Emirates) and Rest of world. China is anticipated to hold a substantial share in the Asia-Pacific sleep apnea devices market. Sleep-related issues such as insufficiency, drowsiness, and insomnia are prevalent among Chinese adolescents. Rapid industrialization and urbanization contribute to career stress and extended nocturnal working hours for young adults, disrupting their natural sleep patterns and resulting in insomnia. The market for sleep apnea diagnostic systems in China is witnessing notable growth due to the escalating prevalence of sleep apnea and a growing demand for accurate and convenient diagnosis. Several factors, including increased awareness of sleep apnea's health implications, advancements in diagnostic technologies, and a rising trend of home sleep testing, contribute to the robust growth of the sleep apnea industry in China.Key Player
Carefusion Corp, Somnomed, ResMed Inc., Koninklijke Philips N.V., Compumedics Limited (CMP), Nihon Kohden Corporation, Natus Medical Incorporated and Teleflex Incorporated are the prominent player in the Sleep Apnea Market.The report titled "Sleep Apnea Devices Market, Global Forecast, by Types [Therapeutics (CPAP Sleep Apnea Therapeutic Devices, Auto CPAP Sleep Apnea Therapeutic Devices, BiPAP Sleep Apnea Therapeutic Devices and Adaptive Servo-Ventilation (ASV)) and Diagnostics (Polysomnography Devices (PSG), Oximeter, Actigraphy Monitoring Device, Respiratory Polygraph and Sleep Apnea Screening Device)], End Users (Sleep Laboratories, Clinics & Hospitals and Home Care Settings/Individuals), Region (North America (United States, Mexico, Canada), Europe (Germany, United Kingdom, France, Italy, Spain, Switzerland), Asia Pacific (Japan, China, India, Australia, South Korea, Indonesia), South America (Brazil, Argentina), Middle East & Africa (South Africa, Saudi Arabia, United Arab Emirates) and Rest of world), Company (Carefusion Corp, Somnomed, ResMed Inc., Koninklijke Philips N.V., Compumedics Limited (CMP), Nihon Kohden Corporation, Natus Medical Incorporated and Teleflex Incorporated)" provides a detailed analysis of Worldwide Sleep Apnea Devices Industry.
Types - Sleep Apnea Devices Market breakup from 2 viewpoints:
1. Therapeutic Devices2. Diagnostic Devices
Therapeutic Devices - Market have been further sub segmented from 4 viewpoints:
1. CPAP Sleep Apnea Therapeutic Devices2. Auto CPAP Sleep Apnea Therapeutic Devices
3. BiPAP Sleep Apnea Therapeutic Devices
4. Adaptive Servo-Ventilation (ASV)
Diagnostic Devices - Market have been further sub segmented from 5 viewpoints:
1. Polysomnography Devices(PSG)2. Oximeter
3. Actigraphy Monitoring Device
4. Respiratory Polygraph
5. Sleep Apnea Screening Device
End User - Sleep Apnea Devices Market breakup from 2 viewpoints:
1. Sleep Laboratories, Clinics & Hospitals2. Home Care Settings/Individuals
Country - Market breakup from Company 21 Sleep Apnea Devices Industry
1. North America1.1 United States
1.2 Canada
2. Europe
2.1 Germany
2.2 United Kingdom
2.3 France
2.4 Italy
2.5 Spain
2.6 Switzerland
3. Asia - Pacific
3.1 Japan
3.2 China
3.3 India
3.4 South Korea
3.5 Indonesia
3.6 Australia
4. Latin America
4.1 Mexico
4.2 Brazil
4.3 Argentina
5. Middle East & Africa
5.1 South Africa
5.2 Saudi Arabia
5.3 United Arab Emirates
6. Rest of World
All key players have been covered from 3 viewpoints:
- Overview
- Recent Development
- Financial Insight
Company Analysis:
1. Carefusion Corp2. Somnomed
3. ResMed Inc.
4. Koninklijke Philips N.V.
5. Compumedics Limited (CMP)
6. Nihon Kohden Corporation
7. Natus Medical Incorporated
8. Teleflex Incorporated
Table of Contents
1. Introduction2. Research & Methodology3. Executive Summary5. Global Sleep Apnea Devices Market
4. Market Dynamic
6. Market Share - Global Sleep Apnea Devices Analysis
7. Product Types - Global Sleep Apnea Devices Market
8. End User - Global Sleep Apnea Devices Market
9. Countries - Global Sleep Apnea Device Market
10. Porter's Five Forces Analysis - Global Sleep Apnea Device Market
11. SWOT Analysis - Global Sleep Apnea Device Market
12. Key Players Analysis
List of Figures:
List of Tables:
Companies Mentioned
- Carefusion Corp
- Somnomed
- ResMed Inc.
- Koninklijke Philips N.V.
- Compumedics Limited (CMP)
- Nihon Kohden Corporation
- Natus Medical Incorporated
- Teleflex Incorporated
Methodology
In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.
Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.
Primary Research
The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develop the analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth, and forecast
The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:
- Chief executives and VPs of leading corporations specific to the industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
- Key opinion leaders (KOLs)
Secondary Research
The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, webcasts, and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
LOADING...
